The University of Southampton
University of Southampton Institutional Repository

p90RSKs mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes

p90RSKs mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes
p90RSKs mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes
Cardiac hypertrophy involves the growth of heart muscle cells and is driven by faster protein synthesis which involves increased ribosome biogenesis. However, the signaling pathways that link hypertrophic stimuli to faster ribosome production remain to be identified.

Here we have investigated the signaling pathways which promote ribosomal RNA synthesis in cardiomyocytes in response to hypertrophic stimulation. We employed a new non-radioactive labeling approach and show that the hypertrophic agent phenylephrine (PE) stimulates synthesis of 18S rRNA (made by RNA polymerase I) and 5S rRNA (produced by RNA polymerase III) in adult cardiomyocytes. In many settings, rRNA synthesis is driven by rapamycin-sensitive signaling through mammalian target of rapamycin complex 1 (mTORC1). However, the activation of rRNA synthesis by PE is not inhibited by rapamycin, indicating that its regulation involves other signaling pathways.

PE stimulates MEK/ERK signaling in these cells. Inhibition of this pathway blocks the ability of PE to activate synthesis of 18S and 5S rRNA. Furthermore, BI-D1870, an inhibitor of the p90RSKs, protein kinases which are activated by ERK, blocks PE-activated rRNA synthesis, as did a second p90RSK inhibitor, SL0101. BI-D1870 also inhibits the PE-stimulated association of RNA polymerase I with the rRNA promoter.

These findings show that signaling via MEK/ERK/p90RSK, not mTORC1, drives rRNA synthesis in adult cardiomyocytes undergoing hypertrophy. This is important both for our understanding of the mechanisms that control ribosome production and, potentially, for the management of cardiac hypertrophy.
ribosome biogenesis, hypertrophy, cardiomyocyte, map kinase, p90rsk
Zhang, Ze
92cb20bf-434e-463a-96a4-7f74c55aa93a
Liu, Rui
f6ba8ec9-4057-4dd9-a960-d63f660eee09
Townsend, Paul A.
a2680443-664e-46d0-b4dd-97456ba810db
Proud, Christopher G.
59dabfc8-4b44-4be8-a17f-578a58550cb3
Zhang, Ze
92cb20bf-434e-463a-96a4-7f74c55aa93a
Liu, Rui
f6ba8ec9-4057-4dd9-a960-d63f660eee09
Townsend, Paul A.
a2680443-664e-46d0-b4dd-97456ba810db
Proud, Christopher G.
59dabfc8-4b44-4be8-a17f-578a58550cb3

Zhang, Ze, Liu, Rui, Townsend, Paul A. and Proud, Christopher G. (2013) p90RSKs mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes. Journal of Molecular and Cellular Cardiology. (doi:10.1016/j.yjmcc.2013.03.006).

Record type: Article

Abstract

Cardiac hypertrophy involves the growth of heart muscle cells and is driven by faster protein synthesis which involves increased ribosome biogenesis. However, the signaling pathways that link hypertrophic stimuli to faster ribosome production remain to be identified.

Here we have investigated the signaling pathways which promote ribosomal RNA synthesis in cardiomyocytes in response to hypertrophic stimulation. We employed a new non-radioactive labeling approach and show that the hypertrophic agent phenylephrine (PE) stimulates synthesis of 18S rRNA (made by RNA polymerase I) and 5S rRNA (produced by RNA polymerase III) in adult cardiomyocytes. In many settings, rRNA synthesis is driven by rapamycin-sensitive signaling through mammalian target of rapamycin complex 1 (mTORC1). However, the activation of rRNA synthesis by PE is not inhibited by rapamycin, indicating that its regulation involves other signaling pathways.

PE stimulates MEK/ERK signaling in these cells. Inhibition of this pathway blocks the ability of PE to activate synthesis of 18S and 5S rRNA. Furthermore, BI-D1870, an inhibitor of the p90RSKs, protein kinases which are activated by ERK, blocks PE-activated rRNA synthesis, as did a second p90RSK inhibitor, SL0101. BI-D1870 also inhibits the PE-stimulated association of RNA polymerase I with the rRNA promoter.

These findings show that signaling via MEK/ERK/p90RSK, not mTORC1, drives rRNA synthesis in adult cardiomyocytes undergoing hypertrophy. This is important both for our understanding of the mechanisms that control ribosome production and, potentially, for the management of cardiac hypertrophy.

This record has no associated files available for download.

More information

Accepted/In Press date: 2013
e-pub ahead of print date: 17 March 2013
Keywords: ribosome biogenesis, hypertrophy, cardiomyocyte, map kinase, p90rsk
Organisations: Cancer Sciences, Centre for Biological Sciences

Identifiers

Local EPrints ID: 350253
URI: http://eprints.soton.ac.uk/id/eprint/350253
PURE UUID: 1b4ef88e-fd0d-477e-bbd8-e05ec894ab22

Catalogue record

Date deposited: 20 Mar 2013 12:53
Last modified: 14 Mar 2024 13:22

Export record

Altmetrics

Contributors

Author: Ze Zhang
Author: Rui Liu
Author: Paul A. Townsend
Author: Christopher G. Proud

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×